This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: F. Hoffmann-La Roche Ag. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Mehrdad Mobasher: Innovator in Cancer Treatment
Introduction
Mehrdad Mobasher is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of oncology, particularly in the treatment of B-cell lymphoma. His work focuses on improving the administration speed of obinutuzumab, a critical drug in cancer therapy.
Latest Patents
Mobasher holds a patent for the treatment of CD20-positive B-cell lymphoma with obinutuzumab. This patent emphasizes the importance of administration speed in enhancing the efficacy of the treatment. His innovative approach aims to optimize patient outcomes in cancer care.
Career Highlights
Mobasher is currently associated with F. Hoffmann-La Roche AG, a leading global healthcare company. His role involves research and development in oncology, where he collaborates with other experts to advance cancer treatment methodologies.
Collaborations
One of his notable coworkers is Michael Wenger, with whom he has worked closely on various projects related to cancer therapies. Their collaboration has contributed to the development of effective treatment strategies.
Conclusion
In summary, Mehrdad Mobasher is a dedicated inventor whose work in cancer treatment is making a significant impact. His patent on the administration of obinutuzumab showcases his commitment to improving patient care in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile